Skip to menu Skip to content Skip to footer

2025

Conference Publication

A Randomized Controlled Trial of Bone-Targeted Exercise for People with Multiple Myeloma: The MyeEx-Impact Study

Nicol, Jennifer, King, Tracy, Chong, Jamie, Cunningham, Brent, Hart, Nicolas, Kay, Shelley, Woodrow, Carmel, Beck, Belinda, McDonald, Michelle, Carter, Daniel, Beer, Hayley, Boytar, Alex, Baguley, Brenton, Farley, Morgan, Rose, Grace, Mollee, Peter and Skinner, Tina (2025). A Randomized Controlled Trial of Bone-Targeted Exercise for People with Multiple Myeloma: The MyeEx-Impact Study. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03992-8

A Randomized Controlled Trial of Bone-Targeted Exercise for People with Multiple Myeloma: The MyeEx-Impact Study

2025

Conference Publication

Early Venetoclax Salvage in Systemic Light Chain Amyloidosis: A Retrospective Case Series

McVilly, Nicholas, Mollee, Peter, Anderson, Nirija Ranjit, Rowland, James, Korczyk, Dariusz, Sheikh, Nabeel and Abro, Emad (2025). Early Venetoclax Salvage in Systemic Light Chain Amyloidosis: A Retrospective Case Series. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03824-8

Early Venetoclax Salvage in Systemic Light Chain Amyloidosis: A Retrospective Case Series

2025

Conference Publication

Outcomes of Patients with Multiple Myeloma Post-BCMA Directed Treatment: An Australian Perspective

Ling, Jessica, Moore, Elizabeth, Wellard, Cameron, Spencer, Andrew, Ho, P. Joy, Mollee, Peter, Harrison, Simon, Augustson, Bradley, Quach, Hang and Sidiqi, M. Hasib (2025). Outcomes of Patients with Multiple Myeloma Post-BCMA Directed Treatment: An Australian Perspective. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03520-7

Outcomes of Patients with Multiple Myeloma Post-BCMA Directed Treatment: An Australian Perspective

2025

Conference Publication

Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis using 18F-Florbetaben Positron Emission Tomography

Anderson, Nirija Ranjit, Law, Phillip, Harrop, Danielle, Ng, Arnold, Wang, William, Korczyk, Dariusz and Mollee, Peter (2025). Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis using 18F-Florbetaben Positron Emission Tomography. International Myeloma Society 22nd Annual Meeting and Exposition, Toronto, Canada, 17-20 September 2025. New York, NY United States: Elsevier. doi: 10.1016/s2152-2650(25)03616-x

Identification of Extracardiac Organ Involvement in Systemic Light Chain Amyloidosis using 18F-Florbetaben Positron Emission Tomography

2025

Journal Article

Visualizing amyloidosis: The role of radionuclide imaging in systemic amyloidosis

Ranjit Anderson, Nirija, Dorbala, Sharmila and Mollee, Peter (2025). Visualizing amyloidosis: The role of radionuclide imaging in systemic amyloidosis. Blood Journal, 146 (10) blood.2024026386, 1157-1162. doi: 10.1182/blood.2024026386

Visualizing amyloidosis: The role of radionuclide imaging in systemic amyloidosis

2025

Journal Article

Sustained improvement in health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone: MAIA final analysis of patient-reported outcomes

Perrot, Aurore, Facon, Thierry, Plesner, Torben, Usmani, Saad Z., Kumar, Shaji, Bahlis, Nizar J., Hulin, Cyrille, Orlowski, Robert Z., Nahi, Hareth, Mollee, Peter, Ramasamy, Karthik, Roussel, Murielle, Jaccard, Arnaud, Delforge, Michel, Karlin, Lionel, Arnulf, Bertrand, Chari, Ajai, Wang, George, Gupta-Werner, Niodita, Kaila, Shuchita, Pei, Huiling, Matt, Kathryn, Gries, Katharine S., Carson, Robin, Borgsten, Fredrik and Weisel, Katja (2025). Sustained improvement in health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone: MAIA final analysis of patient-reported outcomes. European Journal of Haematology, 114 (5), 883-889. doi: 10.1111/ejh.14392

Sustained improvement in health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone: MAIA final analysis of patient-reported outcomes

2025

Journal Article

Presence of 1q21 gain and amplification may be associated with poorer outcomes in Daratumumab-treated Multiple Myeloma patients

Lim, Kenneth J C, Wellard, Cameron, Moore, Elizabeth, Ninkovic, Slavisa, Chng, Wee Joo, Spencer, Andrew, Mollee, Peter, Hocking, Jay, Ho, P. Joy, Janowski, Wojt, Kim, Kihyun, McCaughan, Georgia, Dun, Karen, McQuilten, Zoe, Chen, Fiona and Quach, Hang (2025). Presence of 1q21 gain and amplification may be associated with poorer outcomes in Daratumumab-treated Multiple Myeloma patients. Clinical Lymphoma Myeloma and Leukemia, 25 (4), 243-248. doi: 10.1016/j.clml.2024.11.002

Presence of 1q21 gain and amplification may be associated with poorer outcomes in Daratumumab-treated Multiple Myeloma patients

2025

Journal Article

Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: a systematic review

Sia, Aaron, Chopra, Sakshi, Ling, Victoria Y., Fletcher, James, Hubbard, Ruth Eleanor, Mollee, Peter, Gordon, Emily, Reid, Natasha and Hanjani, Leila Shafiee (2025). Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: a systematic review. Journal of Geriatric Oncology, 16 (3) 102196, 102196. doi: 10.1016/j.jgo.2025.102196

Describing the outcomes of frail patients undergoing treatment with systemic therapies for acute myeloid leukaemia: a systematic review

2025

Journal Article

Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomised controlled trial

Hapgood, Greg, Hill, Kate, Okano, Satomi, Abro, Emad, Looke, David, Kennedy, Glen, Pavilion, Gilbert, Van Kuilenburg, Rosita, Geary, Alanna, Joubert, Warren, Eastgate, Melissa, Jones, Mark and Mollee, Peter (2025). Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomised controlled trial. Journal of Thrombosis and Haemostasis, 23 (2), 627-634. doi: 10.1016/j.jtha.2024.11.002

Catheter-related thrombosis in adults with cancer: a secondary analysis of a prospective randomised controlled trial

2025

Conference Publication

Amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry

Mollee, Peter (2025). Amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry. Pathology Update 2025, Melbourne, VIC Australia, 21-23 February 2025. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.pathol.2024.12.033

Amyloidosis subtyping by laser-capture microdissection and tandem mass spectrometry

2025

Journal Article

A Comparison of Peripherally Inserted Central Catheter Materials

Ullman, Amanda J., August, Deanne, Kleidon, Tricia M., Walker, Rachel M., Marsh, Nicole, Bulmer, Andrew C., Pearch, Ben, Runnegar, Naomi, Leema, Joanne, Lee-Archer, Paul, Biles, Cathy, Gibson, Victoria, Royle, Ruth, Southam, Katrina, Byrnes, Joshua, Chopra, Vineet, Coulthard, Alan, Mollee, Peter, Rickard, Claire M., Harris, Patrick N. A. and Ware, Robert S. (2025). A Comparison of Peripherally Inserted Central Catheter Materials. New England Journal of Medicine, 392 (2), 161-172. doi: 10.1056/nejmoa2406815

A Comparison of Peripherally Inserted Central Catheter Materials

2024

Conference Publication

Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)

Gration, Betty, Wellard, Cameron, Moore, Elizabeth, Mollee, Peter, Kerridge, Ian H., Spencer, Andrew, Shetty, Anita, Baker, Bart, Forsyth, Cecily, Heenan, Jessica, McQuilten, Zoe K, Wood, Erica M. and McCaughan, Georgia (2024). Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR). 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199451

Impact of Socioeconomic Status on Utilisation of ASCT and Overall Survival in Multiple Myeloma: A Report from the Australian and New Zealand (ANZ) Myeloma and Related Diseases Registry (ANZ MRDR)

2024

Conference Publication

Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial Reference

Murali, Aarya, Tobin, Joshua W.D. and Mollee, Peter (2024). Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial Reference. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204199

Plasma Cell Enumeration By Manual and Automated Methods to Establish a Standard Pictorial Reference

2024

Conference Publication

Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG

Mollee, Peter, Huart, Antoine, Mortona, Olga, Queru, Kentin, Leyronnas, Cecile, Stephanie, Harel, Sidiqi, Hasib, Desport, Estelle, Vincent, Laure, Macro, Margaret, Manier, Salomon, Jacquet, Caroline, Morel, Pierre, Horvath, Noemi, Bender, Sebastien, Olombel, Guillaume, Pascal, Virginie, Corre, Jill, Bridoux, Frank, Jaccard, Arnaud and Roussel, Murielle (2024). Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-204700

Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLG

2024

Conference Publication

Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis

Gration, Betty, Wellard, Cameron, Moore, Elizabeth, Tan, Marianne, Murphy, Matthew, Lim, Kenneth J. C., Rowland, James, Hamad, Nada, Rajagopal, Rajeev, Mollee, Peter, Spencer, Andrew, Quach, Hang and McCaughan, Georgia (2024). Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-201790

Treatment of First Relapse of Multiple Myeloma in Australia and New Zealand (ANZ): Treatment Patterns and Outcomes: An ANZ Myeloma and Related Diseases Registry (ANZ MRDR) Analysis

2024

Conference Publication

Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry

Lim, Kenneth J. C., Wellard, Cameron, Moore, Elizabeth, Gration, Betty, Augustson, Bradley, Mollee, Peter, Zhang, Jennifer, Wong Doo, Nicole, Ringkowski, Sabine, Bryant, Adam, Ninkovic, Slavisa, Hamad, Nada, McCaughan, Georgia, Kumar, Shaji, Spencer, Andrew and Quach, Hang (2024). Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-207609

Integrating Chromosomal 1 Abnormalities into the Definition of High-Risk Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry

2024

Conference Publication

An individualised bone-targeted exercise intervention for people with multiple myeloma: study protocol of the MyeEx-impact randomised controlled trial

Chong, Jamie, Nicol, Jennifer, Beck, Belinda, Kay, Shelley, Hart, Nicolas, Carter, Daniel, Woodrow, Carmel, Cunningham, Brent, Farley, Morgan, Boytar, Alexander, Baguley, Brenton, Rose, Grace, Mollee, Peter and Skinner, Tina (2024). An individualised bone-targeted exercise intervention for people with multiple myeloma: study protocol of the MyeEx-impact randomised controlled trial. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.

An individualised bone-targeted exercise intervention for people with multiple myeloma: study protocol of the MyeEx-impact randomised controlled trial

2024

Conference Publication

Comparing the outcomes of frail acute myeloid leukaemia patients undergoing systemic therapy to their fitter counterparts

Sia, Aaron, Chopra, Sakshi, Ling, Victoria, Hubbard, Ruth Eleanor, Mollee, Peter, Gordon, Emily and Hanjani, Leila Shafiee (2024). Comparing the outcomes of frail acute myeloid leukaemia patients undergoing systemic therapy to their fitter counterparts. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13–15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.14117

Comparing the outcomes of frail acute myeloid leukaemia patients undergoing systemic therapy to their fitter counterparts

2024

Conference Publication

Development of a self-reported frailty index - The SELFI

Sia, Aaron Din How, Mollee, Peter, Berry, Robyn, Ladwa, Rahul, Ling, Victoria, Fletcher, James, Gordon, Emily, Walpole, Euan, Hanjani, Leila Shafiee, Reid, Natasha, Simonsen, Camilla and Hubbard, Ruth Eleanor (2024). Development of a self-reported frailty index - The SELFI. COSA's 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 13-15 November 2024. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.14117

Development of a self-reported frailty index - The SELFI

2024

Journal Article

Variation in immunoglobulin use and impact on survival in myeloma

Chai, Khai Li, Wellard, Cameron, Thao, LTP, Aoki, Naomi, Moore, Elizabeth M, Augustson, Bradley M, Bapat, Akshay, Blacklock, Hilary, Chng, Wee J, Cooke, Rachel, Forsyth, Cecily J, Goh, Yeow‐Tee, Hamad, Nada, Harrison, Simon J, Ho, P Joy, Hocking, Jay, Kerridge, Ian, Kim, Jin Seok, Kim, Kihyun, King, Tracy, McCaughan, Georgia J, Mollee, Peter, Morrissey, C Orla, Murphy, Nick, Quach, Hang, Tan, Xuan Ni, Tso, Allison CY, Wong, Kimberly SQ, Yoon, Sung‐Soo ... McQuilten, Zoe K (2024). Variation in immunoglobulin use and impact on survival in myeloma. eJHaem, 5 (4), 690-697. doi: 10.1002/jha2.938

Variation in immunoglobulin use and impact on survival in myeloma